Daily Courier: Single Column

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abivax SA - American Depositary Shares (NQ:ABVX)

119.47 -3.86 (-3.13%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,052,389
Open 122.85
Bid (Size) 118.75 (100)
Ask (Size) 119.99 (100)
Prev. Close 123.33
Today's Range 116.54 - 122.85
52wk Range 4.770 - 148.83
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
From Abivax
Via GlobeNewswire
News headline image
Biotech Exit: $26 Million Arcellx Sale Follows Tepid Stock Performance and Kelonia Competition ↗
Arcellx develops cell-based immunotherapies targeting cancer, with a lead candidate in early-stage trials for multiple myeloma. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-10.7%
-10.7%
1 Month
+0.5%
+0.5%
3 Month
-4.3%
-4.3%
6 Month
+46.3%
+46.3%
1 Year
+1472.0%
+1472.0%

More News

Read More
News headline image
Cogent Biosciences Stock Up 346% as Fund Builds $29 Million Stake After November Phase 3 Breakthrough ↗
Via The Motley Fool
Topics Regulatory Compliance
ABVX Soars Pre-Market On Reports Of $17.5 Billion Eli Lilly Takeover Interest ↗
Via Stocktwits
News headline image
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. ↗
Via The Motley Fool
News headline image
Better Long-Term Buy: This Emerging Player or the Industry Leader? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
Via The Motley Fool
Top movers in Monday's pre-market session ↗
Via Chartmill
News headline image
Abivax Provides 2026 Corporate Outlook
From Abivax
Via GlobeNewswire
News headline image
Is Cidara Therapeutics a Buy After HighVista Strategies Initiated a Position in the Stock? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Could This Potential Move Boost Eli Lilly's Prospects? ↗
Via The Motley Fool
News headline image
The 2025 Growth Postgame: Analyzing the AI Supercycle and Preparing for the 2026 'Agentic' Pivot
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
How Abivax Went From Biotech Nobody To M&A Bullseye After A Single Blockbuster Readout This Year ↗
Via Stocktwits
News headline image
Nasdaq, S&P 500 Futures Head Into Christmas Eve With Caution: Why ASTS, DVAX, ABVX, PATH, GOOGL Are On Traders' Radar Today ↗
Via Stocktwits
Topics ETFs Stocks
News headline image
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
Via MarketMinute
Topics Intellectual Property
News headline image
Why Abivax Stock Was on Fire Today ↗
Via The Motley Fool
News headline image
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Abivax to be Added to Nasdaq Biotechnology Index
From Abivax
Via GlobeNewswire
News headline image
The Great Rotation: Small-Cap Growth Surges as Investors Ditch Defensive Safety for Post-Fed Gains
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings
From Abivax
Via GlobeNewswire
News headline image
Abivax Presents Third Quarter 2025 Financial Results
From Abivax
Via GlobeNewswire
News headline image
2 Under-the-Radar Stocks That Have Soared This Year ↗
Via The Motley Fool

Frequently Asked Questions

Is Abivax SA - American Depositary Shares publicly traded?
Yes, Abivax SA - American Depositary Shares is publicly traded.
What exchange does Abivax SA - American Depositary Shares trade on?
Abivax SA - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Abivax SA - American Depositary Shares?
The ticker symbol for Abivax SA - American Depositary Shares is ABVX on the Nasdaq Stock Market
What is the current price of Abivax SA - American Depositary Shares?
The current price of Abivax SA - American Depositary Shares is 119.47
When was Abivax SA - American Depositary Shares last traded?
The last trade of Abivax SA - American Depositary Shares was at 02/26/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.